WCM Investment Management LLC acquired a new position in shares of Omnicell, Inc. (NASDAQ:OMCL – Free Report) in the 1st quarter, Holdings Channel reports. The fund acquired 302,411 shares of the company’s stock, valued at approximately $9,783,000.
Other large investors have also modified their holdings of the company. Dimensional Fund Advisors LP grew its position in shares of Omnicell by 6.0% during the first quarter. Dimensional Fund Advisors LP now owns 2,450,385 shares of the company’s stock worth $81,791,000 after acquiring an additional 137,834 shares during the last quarter. Bastion Asset Management Inc. acquired a new stake in shares of Omnicell in the 1st quarter valued at approximately $4,638,000. Bank of New York Mellon Corp lifted its holdings in Omnicell by 53.8% in the first quarter. Bank of New York Mellon Corp now owns 433,454 shares of the company’s stock valued at $14,469,000 after acquiring an additional 151,679 shares during the period. Illinois Municipal Retirement Fund boosted its holdings in Omnicell by 21.3% during the first quarter. Illinois Municipal Retirement Fund now owns 25,082 shares of the company’s stock worth $837,000 after buying an additional 4,400 shares in the last quarter. Finally, Principal Financial Group Inc. boosted its stake in shares of Omnicell by 9.8% during the 1st quarter. Principal Financial Group Inc. now owns 296,321 shares of the company’s stock worth $9,891,000 after acquiring an additional 26,441 shares in the last quarter. Institutional investors and hedge funds own 97.70% of the company’s stock.
Analyst Upgrades and Downgrades
Several research analysts recently issued reports on the company. Wall Street Zen upgraded Omnicell from a “buy” rating to a “strong-buy” rating in a research report on Sunday, May 10th. Craig Hallum reiterated a “buy” rating and set a $55.00 price objective on shares of Omnicell in a research report on Wednesday, April 29th. Zacks Research downgraded shares of Omnicell from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, July 7th. Weiss Ratings upgraded shares of Omnicell from a “sell (d)” rating to a “hold (c-)” rating in a report on Thursday, May 7th. Finally, KeyCorp raised their price target on shares of Omnicell from $60.00 to $70.00 and gave the stock an “overweight” rating in a research note on Tuesday, April 28th. Seven equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $59.86.
Insider Activity
In related news, EVP Corey J. Manley sold 5,025 shares of the firm’s stock in a transaction that occurred on Monday, May 18th. The shares were sold at an average price of $43.22, for a total value of $217,180.50. Following the sale, the executive vice president directly owned 112,783 shares of the company’s stock, valued at approximately $4,874,481.26. This trade represents a 4.27% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, EVP Nnamdi Njoku sold 3,090 shares of the business’s stock in a transaction that occurred on Monday, May 18th. The shares were sold at an average price of $43.22, for a total transaction of $133,549.80. Following the completion of the sale, the executive vice president owned 154,785 shares of the company’s stock, valued at approximately $6,689,807.70. The trade was a 1.96% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Corporate insiders own 2.92% of the company’s stock.
Omnicell Price Performance
Shares of NASDAQ:OMCL opened at $45.22 on Tuesday. The company has a market cap of $2.06 billion, a P/E ratio of 102.78, a P/E/G ratio of 1.19 and a beta of 0.96. The company has a quick ratio of 1.29, a current ratio of 1.50 and a debt-to-equity ratio of 0.13. Omnicell, Inc. has a 52 week low of $27.01 and a 52 week high of $55.00. The business has a fifty day simple moving average of $42.61 and a 200-day simple moving average of $41.50.
Omnicell (NASDAQ:OMCL – Get Free Report) last released its earnings results on Tuesday, April 28th. The company reported $0.55 earnings per share for the quarter, topping the consensus estimate of $0.33 by $0.22. Omnicell had a return on equity of 4.00% and a net margin of 1.67%.The firm had revenue of $309.88 million for the quarter, compared to the consensus estimate of $304.02 million. During the same period in the prior year, the business posted $0.26 earnings per share. The firm’s revenue for the quarter was up 14.9% compared to the same quarter last year. Omnicell has set its FY 2026 guidance at 1.800-2.000 EPS and its Q2 2026 guidance at 0.400-48.000 EPS. Equities research analysts forecast that Omnicell, Inc. will post 1.31 EPS for the current year.
Omnicell Company Profile
Omnicell, Inc is a healthcare technology company that specializes in medication management solutions for hospitals, clinics and pharmacies. The company’s offerings encompass automated dispensing cabinets, pharmacy automation systems, IV compounding devices, and software platforms designed to optimize medication usage, streamline workflow and improve patient safety. Omnicell’s analytics and inventory management tools provide real-time visibility into medication utilization, helping healthcare providers reduce waste, manage controlled substances and ensure regulatory compliance.
Founded in Mountain View, California in 1992, Omnicell has grown through both internal innovation and strategic acquisitions to broaden its portfolio across the medication management continuum.
Featured Articles
- Five stocks we like better than Omnicell
- The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence
- Is Domino’s Stock Serving Up a Buying Opportunity?
- A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free
- Why Gold Miners Could Be the Market’s Biggest Comeback Story
Want to see what other hedge funds are holding OMCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Omnicell, Inc. (NASDAQ:OMCL – Free Report).
Receive News & Ratings for Omnicell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omnicell and related companies with MarketBeat.com's FREE daily email newsletter.
